Kyoto, Japan

Hisato Senda


Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 43(Granted Patents)


Location History:

  • Tokyo, JP (1989)
  • Kyoto, JP (1994 - 1997)

Company Filing History:


Years Active: 1989-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hisato Senda: A Pioneer in Medicinal Chemistry

Introduction

Hisato Senda is a notable inventor based in Kyoto, Japan, renowned for his contributions to medicinal chemistry. With a total of four patents to his name, Senda has made significant advancements in chemical compounds that can have profound implications in the pharmaceutical industry.

Latest Patents

Among his latest innovations, Senda has developed Quinolinecarboxylic acid derivatives and salts thereof, as well as oxime derivatives. These oxime derivatives are represented by a complex formula, where variations of alkyl groups and other functional groups showcase the intricate design of these compounds. These innovations have the potential to contribute valuable insights into therapeutic applications.

Career Highlights

Hisato Senda is currently employed at Kaken Pharmaceutical Company, Ltd., where he has played an integral role in research and development. His expertise and innovative mindset have led to substantive advancements in drug design and development, directly impacting the efficacy and utility of pharmaceuticals available in the market.

Collaborations

Throughout his career, Senda has collaborated with esteemed colleagues like Yoshiyuki Zama and Nobuo Ishiyama. Their joint efforts have resulted in a fruitful exchange of ideas and research initiatives, significantly enriching the field of medicinal chemistry.

Conclusion

Hisato Senda's contributions to the realm of medicinal chemistry through his inventive patents emphasize the importance of innovation in the healthcare sector. His continued work at Kaken Pharmaceutical Company and collaborations with other prominent researchers position him as an influential figure in the advancement of pharmaceutical compounds, furthering the potential for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…